Molecular identification and control of apicomplexan parasites

顶复门寄生虫的分子鉴定和控制

• 批准号: 106453-2011
• 负责人: Barta, John
• 金额: $ 2.19万
• 依托单位: University of Guelph
• 依托单位国家: 加拿大
• 项目类别: Discovery Grants Program - Individual
• 财政年份: 2012
• 资助国家: 加拿大
• 起止时间: 2012-01-01 至 2013-12-31
• 项目状态: 已结题
• 来源: https://www.nserc-crsng.gc.ca/ase-oro/Details-Detailles_eng.asp?id=505859
• 关键词: Molecular; identification; control; apicomplexan; parasites

Many of apicomplexan parasites (such as malaria, Toxoplasma and coccidia) are of serious veterinary, agricultural and medical importance. Eimeria are continuing and serious challenges to profitable rearing of commercial poultry (especially chickens). Medication costs and production losses from coccidiosis cost the poultry industry several $100 million each year in Canada. Live vaccines against coccidia are possible but are complicated by immunologically distinct strains of many Eimeria species. We have distinct lines of E. maxima that are similar to one another but do not cross-immunize birds (they do not protect against challenge with the second strain despite their similarity). The few differences that exist between these E. maxima strains must be important targets of a protective immune response. We have determined the window of development of the parasite that is susceptible to control. We propose to conduct a highly detailed molecular dissection of these two parasite strains using transcriptome analysis of these parasites during the time when immunologically relevant molecules are being produced by the parasites. We will examine any differences found for immunological relevance and, when the possible candidate molecules have been identified, vaccination candidates (live vaccines carried by non-pathogenic Salmonella/Bacillus species or via plasmid-based DNA vaccination). This exciting work is the culmination of a long period of research into the interactions that exist between these economically and medically important parasites and their vertebrate hosts.

许多顶复门寄生虫（如疟疾、弓形虫和球虫）在兽医、农业和医学上具有重要意义。艾美耳球虫对商业家禽（特别是鸡）的盈利性饲养构成持续和严重的挑战。在加拿大，球虫病的药物费用和生产损失每年使家禽业损失数亿美元。抗球虫的活疫苗是可能的，但由于许多艾美耳球虫属物种的免疫学上不同的菌株而变得复杂。我们有明显的E线。最大病毒彼此相似，但不交叉免疫鸟类（尽管它们相似，但它们不保护免受第二菌株的攻击）。这些E之间存在的一些差异。maxima菌株必须是保护性免疫应答的重要靶标。 我们已经确定了易受控制的寄生虫的发展窗口。我们建议进行一个非常详细的分子解剖这两种寄生虫株使用这些寄生虫的转录组分析的时间，当免疫相关的分子正在产生的寄生虫。 我们将检查发现的免疫学相关性差异，并在确定可能的候选分子时，检查疫苗候选物（由非致病性沙门氏菌/芽孢杆菌属物种携带的活疫苗或通过基于质粒的DNA疫苗接种）。 这项令人兴奋的工作是对这些经济和医学上重要的寄生虫及其脊椎动物宿主之间存在的相互作用进行长期研究的结果。